These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 36970779)
1. 2D-QSAR, molecular docking and MD simulation based virtual screening of the herbal molecules against Alzheimer's disorder: an approach to predict CNS activity. Thakur A; Sharma B; Parashar A; Sharma V; Kumar A; Mehta V J Biomol Struct Dyn; 2024; 42(1):148-162. PubMed ID: 36970779 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors. Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217 [TBL] [Abstract][Full Text] [Related]
3. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches. Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968 [TBL] [Abstract][Full Text] [Related]
4. Lead Identification Through Agarwal D; Kumar S; Ambatwar R; Bhanwala N; Chandrakar L; Khatik GL Cent Nerv Syst Agents Med Chem; 2024; 24(2):219-242. PubMed ID: 38288823 [TBL] [Abstract][Full Text] [Related]
5. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. Gurung AB; Aguan K; Mitra S; Bhattacharjee A J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776 [TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease. Son M; Park C; Rampogu S; Zeb A; Lee KW Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604 [TBL] [Abstract][Full Text] [Related]
7. Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays. Sahin K; Zengin Kurt B; Sonmez F; Durdagi S J Biomol Struct Dyn; 2020 Jul; 38(11):3342-3358. PubMed ID: 31462153 [TBL] [Abstract][Full Text] [Related]
8. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease. Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408 [TBL] [Abstract][Full Text] [Related]
9. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents. Ambure P; Kar S; Roy K Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease. El Khatabi K; El-Mernissi R; Aanouz I; Ajana MA; Lakhlifi T; Khan A; Wei DQ; Bouachrine M J Mol Model; 2021 Sep; 27(10):302. PubMed ID: 34581863 [TBL] [Abstract][Full Text] [Related]
11. Nguyen HD; Kim MS J Biomol Struct Dyn; 2024 Sep; 42(14):7128-7149. PubMed ID: 37477246 [TBL] [Abstract][Full Text] [Related]
12. Screening and identification of secondary metabolites in the bark of Khare N; Maheshwari SK; Jha AK J Biomol Struct Dyn; 2021 Oct; 39(16):5988-5998. PubMed ID: 32720564 [TBL] [Abstract][Full Text] [Related]
13. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors. Daoud I; Melkemi N; Salah T; Ghalem S Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032 [TBL] [Abstract][Full Text] [Related]
14. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors. Deb PK; Sharma A; Piplani P; Akkinepally RR Mol Divers; 2012 Nov; 16(4):803-23. PubMed ID: 22996404 [TBL] [Abstract][Full Text] [Related]
15. Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silico. Das S; Laskar MA; Sarker SD; Choudhury MD; Choudhury PR; Mitra A; Jamil S; Lathiff SMA; Abdullah SA; Basar N; Nahar L; Talukdar AD Phytochem Anal; 2017 Jul; 28(4):324-331. PubMed ID: 28168765 [TBL] [Abstract][Full Text] [Related]
16. In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment. Innok W; Hiranrat A; Chana N; Rungrotmongkol T; Kongsune P J Comput Aided Mol Des; 2021 Mar; 35(3):325-336. PubMed ID: 33439402 [TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors. Gharaghani S; Khayamian T; Ebrahimi M SAR QSAR Environ Res; 2013; 24(9):773-94. PubMed ID: 23863115 [TBL] [Abstract][Full Text] [Related]
18. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease. Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722 [TBL] [Abstract][Full Text] [Related]
19. Identification of promising inhibitory heterocyclic compounds against acetylcholinesterase using QSAR, ADMET, biological activity, and molecular docking. Nguyen HD; Kim MS Comput Biol Chem; 2023 Jun; 104():107872. PubMed ID: 37119698 [TBL] [Abstract][Full Text] [Related]
20. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques. Abdizadeh R; Hadizadeh F; Abdizadeh T Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]